Stay updated on Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check25 days agoChange DetectedA site-wide banner announces NIH’s transition from the term “artificial intelligence” to “super intelligence” and directs visitors to transition updates and FAQs.SummaryDifference0.5%

- Check32 days agoChange DetectedThe ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedThe site footer’s software revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history now shows Revision: v3.7.0 replacing the previous v3.6.6, indicating a software revision of the page. This reflects an internal update to the page's rendering/versioning rather than content changes to the study information.SummaryDifference0.1%

- Check81 days agoChange DetectedThe study record history now includes a new revision tag, v3.6.6, and removes the previous v3.6.5 tag, updating the visible revision history.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.